Ucb

Ucb Dividend

The Dividend of Ucb (UCB.BR) as of Nov 20, 2026 is 1.39 EUR. In the previous year, Dividend was 1.36 EUR — a change of 2.21% (higher).

Dividend

1.39EUR

YoY

2.21%

Dividend yield

0.50 %

Last updated:

How much dividend does Ucb 2026 pay?

According to the latest status from November 2026, Ucb paid a total of 1.39 EUR per share in dividends within the last 12 months. With the current Ucb price of 280.30 EUR, this corresponds to a dividend yield of 0.48 %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 0.50%. The payout ratio is around 17% of earnings. The dividend has grown at 2.4% per year over the past 19 years.

Historical Ucb Dividends

A dividend is paid times per year. Last year, the payout months were and May.

Historical Ucb Dividends
PaydateDividend
1.45EUR
1.39EUR
1.36EUR
1.33EUR
1.30EUR
1.27EUR
1.24EUR
1.21EUR
1.18EUR
1.15EUR
1.10EUR
1.06EUR
1.04EUR
1.02EUR
1.00EUR
0.98EUR
0.96EUR
0.92EUR
0.92EUR
0.90EUR
0.88EUR
0.86EUR
0.82EUR
0.80EUR
0.76EUR
0.64EUR
0.50EUR
0.38EUR
11.33EUR
1.33EUR
8.67EUR
1.33EUR
6.67EUR
1.35EUR
4.85EUR
1.35EUR
4.44EUR
1.35EUR
4.27EUR
1.33EUR
3.67EUR
1.33EUR
3.47EUR

The Ucb Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2023
1.33 EUR
Jan 1, 2024
1.36 EUR
Jan 1, 2025
1.39 EUR
Jan 1, 2026 (e)
1.45 EUR
Jan 1, 2027 (e)
1.49 EUR
Jan 1, 2028 (e)
1.53 EUR
Jan 1, 2029 (e)
1.57 EUR
Jan 1, 2030 (e)
1.61 EUR
The Ucb Dividend history
YEARDividendYoY
est1.61EUR+2.69%
est1.57EUR+2.69%
est1.53EUR+2.69%
est1.49EUR+2.69%
est1.45EUR+4.32%
1.39EUR+2.21%
1.36EUR+2.26%
1.33EUR+2.31%
1.30EUR+2.36%
1.27EUR+2.42%
1.24EUR+2.48%
1.21EUR+2.54%
1.18EUR+2.61%
1.15EUR+4.55%
1.10EUR+3.77%
1.06EUR+1.92%
1.04EUR+1.96%
1.02EUR+2.00%
1.00EUR+2.04%
0.98EUR+2.08%
0.96EUR+4.35%
0.92EUR0.00%
0.92EUR+2.22%
0.90EUR+2.27%
0.88EUR—

Ucb dividend history and estimates

In 2025, Ucb paid a dividend amounting to 1.39 EUR. Dividend means that Ucb distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.27 EUR
0.00 EUR
Jan 1, 2022
1.30 EUR
0.00 EUR
Jan 1, 2023
1.33 EUR
0.00 EUR
Jan 1, 2024
1.36 EUR
0.00 EUR
Jan 1, 2025
1.39 EUR
0.00 EUR
Jan 1, 2026
1.45 EUR
0.00 EUR
Jan 1, 2027 (e)
0.00 EUR
1.49 EUR
Jan 1, 2028 (e)
0.00 EUR
1.53 EUR

Is the Ucb Dividend Safe?

Ucb has been increasing the dividend for 16 years.

Over the past 10 years, Ucb has increased it by an annual 2.75%.

Over a five-year period, the distribution rose by 2.31%.

Analysts expect a Dividend Increase of 2.14% for the current fiscal year.

Ucb dividend payout ratio

In 2025, Ucb had a payout ratio of 16.95%. The payout ratio indicates the percentage of the company's profits that Ucb distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
23.27 %
Jan 1, 2022
59.77 %
Jan 1, 2023
77.40 %
Jan 1, 2024
24.83 %
Jan 1, 2025
16.95 %
Jan 1, 2026 (e)
10.99 %
Jan 1, 2027 (e)
9.95 %
Jan 1, 2028 (e)
8.39 %

Dividend Details

Understanding Ucb's Dividend Distributions

Ucb’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Ucb's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Ucb's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Ucb’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Ucb Stock analysis

What does Ucb do? The company UCB SA is a Belgian pharmaceutical company that was founded in 1928 and is now active worldwide. The business model of UCB SA is based on the discovery and development of medications for severe diseases. The core competencies of the company are in neurology, immunology, and cardiology. In the history of UCB SA, there are several milestones. In 1961, UCB SA succeeded in synthesizing antihistamines, which marked the beginning of the development of medications for allergic diseases. In the 1990s, UCB SA began to focus on the development of medications for the treatment of epilepsy and Parkinson's disease. In the 2000s, UCB SA acquired several companies, expanding its portfolio of medications and its geographic reach. The company operates three different divisions: pharmaceuticals, biopharmaceuticals, and specialty chemicals. In the pharmaceuticals division, UCB SA develops and distributes medications for the treatment of epilepsy, Parkinson's disease, and autoimmune diseases such as rheumatoid arthritis and lupus. UCB SA's biopharmaceutical division focuses on researching antibodies for the treatment of various diseases such as cancer and multiple sclerosis. In the specialty chemicals division, UCB SA produces chemical products such as solvents and paints. The company offers a wide range of products tailored to the needs of patients with various diseases. One example of a well-known product from UCB SA is Keppra, a medication for the treatment of epilepsy. Keppra is one of the most prescribed medications for epilepsy and has helped improve the lives of millions of patients. Another example is Cimzia, a medication for the treatment of rheumatoid arthritis, Crohn's disease, and ulcerative colitis. Cimzia belongs to a new generation of medications that aim to selectively influence the immune system and thus inhibit inflammation. UCB SA places great value on innovation and constantly researches new medications and therapies. The company has a strong research and development team with over 3,000 employees and invests approximately 25% of its revenue annually in the research and development of new medications. Overall, UCB SA is an innovative and successful pharmaceutical company with a broad portfolio of medications and a strong commitment to the quality of the products developed. The company is dedicated to improving the lives of patients with severe diseases and remains a key player in the global pharmaceutical industry in the long term. Ucb is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ucb stock

Over the past 12 months, Ucb paid a dividend of 1.39 EUR . This corresponds to a dividend yield of about 0.50 %. For the coming 12 months, Ucb is expected to pay a dividend of 1.49 EUR.

The current dividend yield of Ucb is 0.50 %.

Ucb pays a dividend, distributed in the months of April, May.

Ucb paid dividends every year for the past 35 years.

For the upcoming 12 months, dividends amounting to 1.49 EUR are expected. This corresponds to a dividend yield of 0.52 %.

Ucb is assigned to the 'Health' sector.

In the year 2025, Ucb distributed 1.39 EUR as dividends.

The dividends of Ucb are distributed in EUR.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Ucb